SecBot SecBot

NXTS

Nexentis Technologies Inc.
Nasdaq· Agricultural Chemicals· Inc. NV· CIK 0001789192 Materials & Mining
$0.5623 +0.04 (+7.31%)
Oct 26 4:00 PM ET · prev $0.5240
Market cap
$1.7M
Nano cap
1 year
−97.8%
from $26.04 · Oct 27
30 days
−61.6%
from $1.47
52-week range
$0.5240–26.04
−98% from high · low Oct 23
Avg volume 20D
1.03M
Oct 7 spike 18.42M
Short interest
37.7K
≈2.5% of shares · −4.4%
Days to cover
1.0
at average volume
Insider net
−$172.09
0 buyers · 1 seller · 12 mo
Filing reports
9
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 1/2
Strongest NEUTRAL Nexentis Technologies Inc. (NXTS) filed an 8-K disclosing multiple warrant agreements, including an…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $172.09.

  • Short sellersSTEADY

    Short interest −4.4% to 37.7K shares. 1.0 days to cover, ≈2.5% of shares.

  • TrendDOWNTREND

    59% below its 50-day average. New closing low $0.5240 on Oct 23.

Who's buying

13F
Top holderSharesValue
HRT FINANCIAL LP45,240$194.0K
VANGUARD FIDUCIARY TRUST CO998$4.3K
BARCLAYS PLC1$4.00

Quarterly 13F filings are due 45 days after each quarter ends.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 Other
🔒 Fresh data, subscribers only
Oct 19, 2026 SEC
Nexentis Technologies issued 922,188 shares of common stock as compensation to officers, directors, and consultants…
8-K — Impact 3/10
Oct 15, 2026 Insider
Barda Lital was granted 51,000 shares
Chief Financial Officer
Oct 15, 2026 Insider
Weiss Amitay was granted 101,549 shares
Director
Oct 15, 2026 Insider
Berenstein Israel Yakov was granted 19,375 shares
Director
Oct 6, 2026 SEC
Nexentis Technologies Inc. (NXTS) filed an 8-K disclosing multiple warrant agreements, including an amendment and…
8-K — Impact 4/10
Jul 20, 2026 SEC
Nexentis Technologies Inc. (NXTS) received SEC effectiveness for its S-1 registration statement (File No. 333-297425)…
EFFECT — Impact 4/10

Insider ledger

Form 4
$0
bought · 0 insiders
$172.09
sold · 1 insider
DateInsiderTypeValue
Oct 15, 2026
Barda Lital
Chief Financial Officer
AWARD51,000 sh
Oct 15, 2026
Weiss Amitay
Director
AWARD101,549 sh
Oct 15, 2026
Berenstein Israel Yakov
Director
AWARD19,375 sh
Oct 15, 2026
Sidi Liat
Director
AWARD14,795 sh
Oct 15, 2026
Arbib Eliahou
Director
AWARD19,375 sh
Oct 15, 2026
Palach David
Chief Executive Officer
AWARD101,549 sh
Oct 15, 2026
Rosenbloom Ronen
Director
AWARD19,375 sh
Oct 15, 2026
Zakai Shlomo
Controller
AWARD51,000 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
37,720
shares short
-4.4%
vs prior settlement
1.0
days to cover
≈2.5%
of shares outstanding
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 26, 2026
Press release
🔒 Fresh data, subscribers only
Sep 24, 2026
Press release
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
Leading computational chemistry expert to advise MitoCareX as it expands its in silico drug-discovery capabilities
Sep 23, 2026
Press release
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
Evaluation of additional commercially available approaches for obtaining proteins is intended to enhance access to research materials, increase…
Sep 8, 2026
Listing
Listing Status: NXTS — Deficient (was Normal)
Nexentis Technologies Inc. - Common Stock | Nasdaq Financial Status Indicator N → D
Jun 29, 2026
Press release
Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment
Neve Yarak, Israel, June 29, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ: NXTS) (“Nexentis” or the “Company”), a drug discovery…

SecBot reports

9 filings · 0 bullish · 5 bearish · 4 neutral
All NXTS filing & press-release reports (9)